Effects of an angiotensin Ii receptor antagonist (valsartan) on macro- and microcirculatory hemodynamics of the arm in hypertensive patients
Marchi, S.D.; Prior, M.; Zannoni, M.; Lucchese, L.; Arosio, E.
Minerva Cardioangiologica 47(12): 554-556
1999
ISSN/ISBN: 0026-4725 PMID: 10670200 Document Number: 505094
Document emailed within 1 workday
Related Documents
Sasaki, K.; Kushiro, T.; Nakagawa, S.; Kanmatsuse, K. 1999: Effects of angiotensin Ii receptor antagonist on insulin sensitivity and sympathetic activity in spontaneously hypertensive rats Nihon Jinzo Gakkai Shi 41(7): 692-696Dang, A.-m.; Liu, G.-z.; Zhang, Y.-h.; Chen, G.-l. 2006: The effects of angiotensin Ii receptor blockers in hypertensive patients complicating hyperuricaemia Zhonghua Xin Xue Guan Bing Za Zhi 34(10): 882-885
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Zhou, H.; Bian, Y-fei.; Li, M-lian.; Gao, F.; Xiao, C-shi. 2010: Effects of RNA interference targeting angiotensin 1 receptor and angiotensin-converting enzyme on blood pressure and myocardial remodeling in spontaneous hypertensive rats Zhonghua Xin Xue Guan Bing Za Zhi 38(1): 60-66
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703
Abe, Y.; Sakamoto, W.; Fukui, K.; Iwao, H.; Takada, T.; Yamamoto, K. 1988: Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats Archives Internationales de Pharmacodynamie et de Therapie 292: 237-247
Li, X.C.; Widdop, R.E. 1995: Regional hemodynamic effects of the AT1 receptor antagonist CV-11974 in conscious renal hypertensive rats Hypertension 26(6 Pt 1): 989-997
Yu, M.; Gopalakrishnan, V.; McNeill, J.R. 1998: Hemodynamic effects of a selective endothelin--a receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats Journal of Cardiovascular Pharmacology 31(Suppl): S262-S264
Kim, S.; Iwao, H. 1997: Involvement of angiotensin Ii in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 15(6): S3-S7
Tachikawa, H.; Kodama, M.; Hui, L.; Yoshida, T.; Hayashi, M.; Abe, S.; Kashimura, T.; Kato, K.; Hanawa, H.; Watanabe, K.; Nakazawa, M.; Aizawa, Y. 2003: Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis Journal of Cardiovascular Pharmacology 41(Suppl): S105-S110
Kitamura, Y.; Pegram, B.L.; Kawamura, H.; Frohlich, E.D. 1984: Effects of alpha-receptor inhibition by phentolamine on systemic and regional hemodynamics in spontaneously hypertensive rats Nihon Jinzo Gakkai Shi 26(9): 1223-1233
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Sato, N.; Kase, H.; Kato, T.; Kasai, K. 2003: Effect of angiotensin Ii type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1245-1249
Ogihara, T.; Nakamaru, M.; Higaki, J.; Hata, T.; Kumagai, A.; Kumahara, Y. 1983: A comparison of biological effects of three angiotensin Ii antagonists in sodium depleted hypertensive patients Medical Journal of Osaka University 34(1-2): 21-25
Nitenberg, A.; Antony, I. 1998: Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients European Heart Journal 19(Suppl): J45-J51
Stearns, R.A.; Doss, G.A.; Miller, R.R.; Chiu, S.H. 1991: Synthesis and identification of a novel tetrazole metabolite of the angiotensin Ii receptor antagonist DuP 753 Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(6): 1160-1162
Colletti, A.E.; Krieter, P.A. 1994: Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys Drug metabolism and disposition: the biological fate of chemicals 22(2): 183-188
Ebisu, H.; Nishikawa, M.; Tanaka, M.; Okazoe, T.; Morizawa, Y.; Shinyama, H.; Nakamura, N. 1999: Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist Journal of Cardiovascular Pharmacology 34(4): 526-532